12th International Symposium for Mechanisms of Vasodilatation: Celebrating the 30th Anniversary of the Announcement of NO as a Vasodilator Molecule
The format of the meeting has not changed much since its inception, with a program built around abstracts submitted by the participants, with the exception over the years of the addition of named lectures (Table 2) honoring those who have made major contributions to discoveries, leading to our understanding of vascular function in general and vasodilatation in particular: John T. Shepherd for his seminal work on the reflex control of vascular tone; Robert F. Furchgott for the discovery of EDRF and NO; David F. Bohr for his pursuit of the understanding of the mechanisms controlling calcium homeostasis in vascular smooth muscle; Björn Folkow for unraveling the role of myogenic tone and demonstrating the importance of remodeling of the vascular wall; and Paul M. Vanhoutte for his efforts in adjusting vascular pharmacology to pathophysiology. The named lecturers were nominated by their peers and selected by vote of an international panel of established scientists. New and emerging concepts of mechanisms of vascular control given by the named lecturers at the 2016 MOVD are contained in this issue of the Journal of Cardiovascular Pharmacology.
These distinguished scientists set the stage and entice future researchers to make discoveries into the basic mechanisms of vasodilatation that will help to provide information to develop new preventive and therapeutic targets to reduce the burden of cardiovascular disease for future generations. The tradition of named lecturers will continue because the next MOVD meeting is already planned in 2019 in Rotterdam, the Netherlands, under the expert guidance of Jan Danser, PhD, Head of the Laboratory of Pharmacology, Erasmus Medical College.